Abstract
The factor-V-Leiden mutation is seen in high frequencies in white people, despite its contribution to second-trimester abortion, preterm birth, and deep-vein thrombosis. The reason for its high frequency is not known. We investigated 102 mother-child pairs who had had successful in-vitro fertilisation by intracytoplasmic sperm injection as a model for human implantation. In 90% (9 of 10) of mother-child pairs who carried factor-V-Leiden mutation, the first embryo transfer was successful, compared with 49% (45 of 92) in factor-V-Leiden negative pairs (p=0.018, Fisher's exact test). Furthermore, the median number of unsuccessful transfers was lower in pairs who were positive for the mutation (0, range 0-2) than those who were negative (1, 0-8) (p=0.02, Mann Whitney U test) suggesting that improved implantation rate is an important genetic advantage of the factor-V-Leiden mutation.
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Lancet |
| Jahrgang | 358 |
| Ausgabenummer | 9289 |
| Seiten (von - bis) | 1238-1239 |
| Seitenumfang | 2 |
| ISSN | 0140-6736 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 13.10.2001 |
Fördermittel
This work was supported by grant Go 955/1–1 from the Deutsche Forschungsgemeinschaft and by Grant J 10 from the University of Lübeck.
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
-
SDG 5 – Gender Equality
Strategische Forschungsbereiche und Zentren
- Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)
Fingerprint
Untersuchen Sie die Forschungsthemen von „Selection pressure for the factor-V-Leiden mutation and embryo implantation“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver